Delivery Order SPE2DB20D1047-SPE2DB25FF63A

Award Date 5/22/25
Potential Completion Date 5/23/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARMODAFINIL 250 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,835.82 and a completion date of May 30, 2025. The contract is a firm fixed-price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARMODAFINIL 250 MG TABLET 30S, with a ceiling value of $5,400.42 and a period of performance through May 22, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARMODAFINIL 250 MG TABLET 30S, a pharmaceutical product, with a firm fixed price of $2,787.50 and a performance period ending on May 29, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARMODAFINIL 250 MG TABLET 30S, with a firm fixed price of $2,529.31 and a completion date of May 22, 2025. The contract is not set aside and was awarded under Amerisourcebergen Drug Corp's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARMODAFINIL 250 MG TABLET 30S, with a firm fixed-price ceiling value of $2,096.21 and a completion date of May 28, 2025. The contract is not designated as a set-aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARMODAFINIL 250MG 30S, a prescription medication, with a ceiling value of $1,672.50 and a period of performance through June 12, 2025. The contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,793.26 firm fixed-price contract is for the delivery of 4567733105 ARMODAFINIL 250 MG TABLET 30S and has an ultimate completion date of March 31, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,039.60, is for the delivery of Armodafinil 250 mg tablets. It is a firm fixed-price, non-set-aside contract with a performance period ending on May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Armodafinil 250 mg tablets, a medication used to treat sleep disorders. The contract has a ceiling value of $3,206.57 and a period of performance through April 8, 2025. It is a Firm Fixed Price contract, indicating a pre-determined price for the products. This order is not designated as a set-aside contract,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,192,477 units of the prescription medication armodafinil 250 mg tablets. The contract has a firm fixed price of $1,672.35 and a completion date of May 9, 2025. This award is not set-aside and represents open competition. Amerisourcebergen Drug Corp holds a larger Indefinite...
  • SPE2DB20D1047
    Indefinite Delivery Contract
  • SPE2DB20D1047-SPE2DB25FF63A
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARMODAFINIL 250 MG TABLET 30S, a pharmaceutical product, with a firm fixed-price ceiling value of $1,114.90 and an ultimate completion date of May 23, 2025.

The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit company registered in the System for Award Management (SAM.gov) and is a critical supplier of medical and pharmaceutical products to federal agencies, particularly the DLA. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products and medical supplies to various government agencies, including the Defense Health Agency and the U.S. Coast Guard.

Generated 8/21/25, 9:59 AM